Literature DB >> 22686078

[Urine metabonomic study on hypertension patients of ascendant hyperactivity of gan yang syndrome by high performance liquid chromatography coupled with time of flight mass spectrometry].

Hai-Qiang Jiang1, Yun-Lun Li, Jun Xie.   

Abstract

OBJECTIVE: To study the changes of urine metabolites in hypertension patients of ascendant hyperactivity of Gan yang syndrome (AHGYS), and to explore its essence in hypertension patients.
METHODS: Ten typical hypertension patients of AHGYS were recruited as the patient group, and the other twelve healthy volunteers were recruited as the normal group. The metabolite profiling in the urine were collected using by high performance liquid chromatography coupled with time of flight mass spectrometry (HPLC-TOFMS). The principal component analysis (PCA) and partial least-square discriminant analysis (PLS-DA) were analyzed using SIMCA-P Software. The differential metabolites in the urine were found out and identified. The possible relevant metabolic pathways were explained.
RESULTS: The data from the analysis by PCA in the urine samples of the patient group and the normal group showed, two sets of data could be obviously classified in the score plot. Compared with the normal group, significant changes happened to the body metabolism in the patient group. The metabolites relevant to hypertension patients of AHGYS were determined using the PLS-DA. Fifteen compounds of the structure and metabolic pathways had been confirmed through inquiring KEGG Database, mainly including amino acids, free fatty acids, sphingosine, and so on.
CONCLUSIONS: The hypertension patients of AHGYS were studied using HPLC-TOFMS combined with pattern recognition, thus finding out small molecular metabolic markers from the microscopic field, which was advantageous in probing the biological nature of Chinese medicine syndromes.

Entities:  

Mesh:

Year:  2012        PMID: 22686078

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  6 in total

1.  An integrated metabonomic and proteomic study on Kidney-Yin Deficiency Syndrome patients with diabetes mellitus in China.

Authors:  Ning Jiang; Hong-fang Liu; Si-di Li; Wen-xia Zhou; Yong-xiang Zhang; Qi Zhang; Xian-zhong Yan
Journal:  Acta Pharmacol Sin       Date:  2015-05-04       Impact factor: 6.150

Review 2.  Adaption and application of the four phase trials to traditional chinese medicines.

Authors:  M Y Di; J L Tang
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-20       Impact factor: 2.629

3.  Clinical Applications of Omics Technologies on ZHENG Differentiation Research in Traditional Chinese Medicine.

Authors:  Ya-Nan Song; Gui-Biao Zhang; Yong-Yu Zhang; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-18       Impact factor: 2.629

4.  ZHENG-Omics Application in ZHENG Classification and Treatment: Chinese Personalized Medicine.

Authors:  Jianye Dai; Junwei Fang; Shujun Sun; Qiwen Chen; Huijuan Cao; Ningning Zheng; Yongyu Zhang; Aiping Lu
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-03       Impact factor: 2.629

5.  Tianma gouteng yin as adjunctive treatment for essential hypertension: a systematic review of randomized controlled trials.

Authors:  Jie Wang; Bo Feng; Xiaochen Yang; Wei Liu; Yongmei Liu; Yun Zhang; Gui Yu; Shengjie Li; Yuqing Zhang; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-24       Impact factor: 2.629

6.  Randomized Controlled Trials of Tianma Gouteng Decoction Combined with Nifedipine in the Treatment of Primary Hypertension: A Systematic Review and Meta-Analysis.

Authors:  Jia Tai; Junbo Zou; Xiaofei Zhang; Yu Wang; Yulin Liang; Dongyan Guo; Mei Wang; Chunli Cui; Jing Wang; Jiangxue Cheng; Yajun Shi
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-07       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.